Clinical Trial Update: Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections [Phase 2]

View source ↗

Summary

Phase 2 trial comparing CEM-102 to linezolid for acute bacterial skin infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin Infections
• Skin Diseases

Drugs mentioned

• CEM-102
• Linezolid (Linezolid)

Snippet

Sponsor: Arrevus Inc. | Conditions: Skin Diseases, Bacterial | Phase 2 | Status: COMPLETED